Skip to main content
. 2011 Dec 5;3(2):341–346. doi: 10.3892/etm.2011.407

Figure 1.

Figure 1.

Immunohistochemical staining of MAD2 in locally advanced cervical cancer. (A) Negative control; (B) Group NAC+R, score 1; (C) Group NAC+OP+R, score 12; (A–C, H&E, x400). MAD2 was expressed in the nuclei of the tumor cells. MAD2, mitotic arrest deficiency 2; NAC+R, neoadjuvant chemotherapy + radiotherapy; NAC+OP+R, neoadjuvant chemotherapy + surgery + radiotherapy; H&E, hematoxylin and eosin.